MetaCap

BioNexus Gene Lab Earnings

NASDAQ: BGLCHealth CareMedical SpecialitiesUSD

0.680.00 (0.00%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BioNexus Gene Lab earnings summary

In its most recent report on Nov 19, 2026 (Sep/2026), BGLC posted EPS of $-0.39.

Summary generated from market data by MetaCap's automated system. Methodology

BGLC earnings history

BioNexus Gene Lab reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Nov 19, 2026—$-0.39——
Nov 13, 2026—$-0.39—-17.2%
Aug 14, 2026—$-0.118——
May 15, 2026—$-0.225——
Nov 14, 2025—$-0.395——
Aug 18, 2025—$-0.343——
May 15, 2025—$-0.347——
Nov 15, 2024—$-0.749——
Aug 14, 2024—$0.113——
May 15, 2024—$-0.006——
Nov 15, 2021—$0.00——
Aug 12, 2021—$0.00——
May 18, 2021—$0.00——
Mar 30, 2021—$0.01——
Nov 3, 2020—$0.00——
Aug 11, 2020—$0.00——

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related